Senores Pharmaceuticals Ltd (SENORES) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 10039497,
    "name": "Senores Pharma.",
    "stock_name": "Senores Pharma.",
    "full_name": "Senores Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/senores-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,309.40",
    "chg": 38.95,
    "chgp": "3.07%",
    "dir": 1,
    "prev_price": "1,270.45",
    "mcapval": "5,925.00 Cr",
    "mcap": "Small Cap",
    "scripcode": "544319",
    "symbol": "SENORES",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0RB801010",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "6.44 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/senores-pharma-10039497-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Senores Pharmaceuticals Ltd Valuation Shifts Amid Strong Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-valuation-shifts-amid-strong-market-performance-3997953",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_valuationdot_3997953.png",
        "date": "2026-05-19 08:03:11",
        "description": "Senores Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive classification, despite robust stock price gains and strong operational metrics. This article analyses the evolving price attractiveness of the small-cap pharmaceutical player in the context of its peer group and historical benchmarks."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Senores Pharmaceuticals Ltd to 52-Week High of Rs 985",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-new-52-week-high-at-rs985-3989573",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_priceRelatedfactors_3989573.png",
        "date": "2026-05-13 12:40:34",
        "description": "From a 52-week low of Rs 491 to a fresh peak of Rs 985, Senores Pharmaceuticals Ltd has nearly doubled in value over the past year, outpacing the Sensex which declined by 7.8% during the same period. This milestone reflects a powerful confluence of technical momentum and improving fundamentals that have propelled the stock to new heights on 13 May 2026."
      },
      {
        "title": "Senores Pharmaceuticals Ltd Hits All-Time High of Rs 983.65 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-all-time-high-amid-robust-financial-performance-3989561",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_priceRelatedfactors_3989561.png",
        "date": "2026-05-13 12:17:40",
        "description": ""
      },
      {
        "title": "Broad-Based Technical Strength Lifts Senores Pharmaceuticals Ltd to 52-Week High of Rs 980.35",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-new-52-week-high-at-rs98035-3985591",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_priceRelatedfactors_3985591.png",
        "date": "2026-05-11 11:11:04",
        "description": "Surpassing the Rs 980 mark on 11 May 2026, Senores Pharmaceuticals Ltd has reached a fresh 52-week high, marking a remarkable doubling in its share price from the low of Rs 491 over the past year. This milestone is underpinned by a confluence of robust technical indicators and sustained price momentum, even as broader market indices like the Sensex have retreated."
      },
      {
        "title": "Senores Pharmaceuticals Ltd Hits All-Time High of Rs 979.50 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-all-time-high-amid-robust-financial-performance-3985552",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_priceRelatedfactors_3985552.png",
        "date": "2026-05-11 10:47:32",
        "description": ""
      },
      {
        "title": "Senores Pharmaceuticals Gains 8.28%: 4 Key Factors Driving the Week’s Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-gains-828-4-key-factors-driving-the-weeks-rally-3982612",
        "imagepath": "",
        "date": "2026-05-09 09:04:00",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>May 5:</strong> Technical momentum shifts amid mixed indicator signals</p>\n                    <p><strong>May 8:</strong> New 52-week high of Rs.959</p>\n                    <p><strong>May 8:</strong> All-time high reached at Rs.957.70</p>\n                    <p><strong>May 8:</strong> Multibagger returns highlighted amid robust growth and institutional interest</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.892.65</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.966.55</div><div cl..."
      },
      {
        "title": "102% Stock Return, 20% Profit Growth: What's Driving Senores Pharmaceuticals Ltd's Multibagger Rerating?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-delivers-multibagger-returns-amid-robust-growth-and-institutional-interest-3981811",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_multibagger_3981811.png",
        "date": "2026-05-08 13:35:03",
        "description": "A 102.36% stock return in one year. An 11.49% growth in net profit over the same period. The gap between those two numbers — roughly 90 percentage points — is driven largely by the market's willingness to pay a higher multiple for each rupee of Senores Pharmaceuticals Ltd's earnings. That divergence is the key to understanding the recent rerating."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Senores Pharmaceuticals Ltd to 52-Week High of Rs 959",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-new-52-week-high-of-rs959-3981677",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_priceRelatedfactors_3981677.png",
        "date": "2026-05-08 11:10:25",
        "description": "With a near doubling in price from Rs 474 to Rs 959 over the past year, Senores Pharmaceuticals Ltd has surged to a fresh 52-week high on 8 May 2026, propelled by a confluence of robust technical indicators and sustained price momentum."
      },
      {
        "title": "Senores Pharmaceuticals Ltd Hits All-Time High of Rs 957.70 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-all-time-high-amid-robust-financial-performance-3981622",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_priceRelatedfactors_3981622.png",
        "date": "2026-05-08 10:42:25",
        "description": "Extending its winning streak to four sessions, Senores Pharmaceuticals Ltd surged 2.71% on 8 May 2026 to close at a fresh all-time high of Rs 957.70, just 0.81% above its previous 52-week peak. This rally comes amid broad outperformance against the Sensex, which declined 0.43% on the same day, underscoring the stock’s robust momentum across multiple timeframes."
      }
    ],
    "total": 15,
    "sid": "10039497",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/senores-pharmaceuticals-10039497"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer",
      "datetime": "10-Jun-2026",
      "details": "Senores Pharmaceuticals Limited has informed the Exchange regarding Cessation of Company Secretary and Compliance Offer w.e.f. June 10 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015",
      "datetime": "10-Jun-2026",
      "details": "Senores Pharmaceuticals Limited has informed the Exchange regarding update in terms of Regulation 30(5) of SEBI (LODR) Regulations 2015",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "09-Jun-2026",
      "details": "Senores Pharmaceuticals Limited has informed the Exchange regarding Analyst/Institutional Investor meet scheduled to be held on June 12 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Senores Pharmaceuticals Ltd Valuation Shifts Amid Strong Market Performance

2026-05-19 08:03:11

Senores Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive classification, despite robust stock price gains and strong operational metrics. This article analyses the evolving price attractiveness of the small-cap pharmaceutical player in the context of its peer group and historical benchmarks.

Broad-Based Technical Strength Lifts Senores Pharmaceuticals Ltd to 52-Week High of Rs 985

2026-05-13 12:40:34

From a 52-week low of Rs 491 to a fresh peak of Rs 985, Senores Pharmaceuticals Ltd has nearly doubled in value over the past year, outpacing the Sensex which declined by 7.8% during the same period. This milestone reflects a powerful confluence of technical momentum and improving fundamentals that have propelled the stock to new heights on 13 May 2026.

Senores Pharmaceuticals Ltd Hits All-Time High of Rs 983.65 as Momentum Builds Across Timeframes

2026-05-13 12:17:40

Broad-Based Technical Strength Lifts Senores Pharmaceuticals Ltd to 52-Week High of Rs 980.35

2026-05-11 11:11:04

Surpassing the Rs 980 mark on 11 May 2026, Senores Pharmaceuticals Ltd has reached a fresh 52-week high, marking a remarkable doubling in its share price from the low of Rs 491 over the past year. This milestone is underpinned by a confluence of robust technical indicators and sustained price momentum, even as broader market indices like the Sensex have retreated.

Senores Pharmaceuticals Ltd Hits All-Time High of Rs 979.50 as Momentum Builds Across Timeframes

2026-05-11 10:47:32

Senores Pharmaceuticals Gains 8.28%: 4 Key Factors Driving the Week’s Rally

2026-05-09 09:04:00

Key Events This Week May 5: Technical momentum shifts amid mixed indicator signals May 8: New 52-week high of Rs.959 May 8: All-time high reached at Rs.957.70 May 8: Multibagger returns highlighted amid robust growth and institutional interest Week OpenRs.892.65 Week CloseRs.966.55<div cl...

102% Stock Return, 20% Profit Growth: What's Driving Senores Pharmaceuticals Ltd's Multibagger Rerating?

2026-05-08 13:35:03

A 102.36% stock return in one year. An 11.49% growth in net profit over the same period. The gap between those two numbers — roughly 90 percentage points — is driven largely by the market's willingness to pay a higher multiple for each rupee of Senores Pharmaceuticals Ltd's earnings. That divergence is the key to understanding the recent rerating.

Broad-Based Technical Strength Lifts Senores Pharmaceuticals Ltd to 52-Week High of Rs 959

2026-05-08 11:10:25

With a near doubling in price from Rs 474 to Rs 959 over the past year, Senores Pharmaceuticals Ltd has surged to a fresh 52-week high on 8 May 2026, propelled by a confluence of robust technical indicators and sustained price momentum.

Senores Pharmaceuticals Ltd Hits All-Time High of Rs 957.70 as Momentum Builds Across Timeframes

2026-05-08 10:42:25

Extending its winning streak to four sessions, Senores Pharmaceuticals Ltd surged 2.71% on 8 May 2026 to close at a fresh all-time high of Rs 957.70, just 0.81% above its previous 52-week peak. This rally comes amid broad outperformance against the Sensex, which declined 0.43% on the same day, underscoring the stock’s robust momentum across multiple timeframes.

View All News